Back

SELECT and STEP-HFpEF: new horizons.

27 August 2022 (10:40 - 10:50)
Organised by:
Congress Presentation Part of: Targeting cardiovascular risk factors with GLP-1 RAs in people with obesity Obesity and Diabetes Open Access ESC Congress 2022

About the speaker

Photo
Professor A Michael Lincoff

Cleveland Clinic Hospital, Cleveland (United States of America)

4 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor A. Lincoff (Cleveland, US)
Video
Presentation thumbnail
CV risk: what's weight got to do with it?
Professor J. Deanfield (London, GB)
Video
Presentation thumbnail
Improvements in CV risk factors: STEP by STEP.
Doctor B. Scirica (Boston, US)
Video
Presentation thumbnail
Panel discussion.
Professor J. Deanfield (London, GB) Professor A. Lincoff (Cleveland, US) Doctor B. Scirica (Boston, US)
Video

Access the full session

Session thumbnail
Targeting cardiovascular risk factors with GLP-1 RAs in people with obesity
Video

The Event

Event poster

ESC Congress 2022

27 August 2022 10:40 CET
You may be interested in
thumbnail
Congress Presentation
GLP-1 RA as first-line therapy to improve outcomes?
1 September 2024
thumbnail
Congress Session
GLP-1RAs in obesity-related HFpEF: a new era in treatment
31 August 2025
thumbnail
Congress Session
Clinical trial updates on the GLP-1 receptor agonist, semaglutide
30 August 2024
thumbnail
Congress Presentation
Current approaches to the prevention and management of obesity
2 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources